Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of nanotechnology to combat liver cancer: Progress and perspectives
Keenan J. Mintz, Roger M. Leblanc
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188621-188621
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 93
Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery
Liu Cui, Xi Wang, Zhaoyun Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 240, pp. 124370-124370
Closed Access | Times Cited: 57
Recent Advances and Clinical Potential of Near Infrared Photothermal Conversion Materials for Photothermal Hepatocellular Carcinoma Therapy
Ruiliang Ge, Pei-ning Yan, Yang Liu, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 29
Closed Access | Times Cited: 57
NANOTECHNOLOGY-DRIVEN THERAPEUTICS FOR LIVER CANCER: CLINICAL APPLICATIONS AND PHARMACEUTICAL INSIGHTS
Lokeshvar Ravikumar, RAMAIYAN VELMURUGAN, Nithin Vidiyala, et al.
Asian Journal of Pharmaceutical and Clinical Research (2025), pp. 8-26
Open Access | Times Cited: 2
Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinoma
Qin Shi, Wen Zhang, Yongjie Zhou, et al.
Biomaterials (2024) Vol. 306, pp. 122480-122480
Closed Access | Times Cited: 11
Biomembrane‐coated nanosystems as next‐generation delivery systems for the treatment of gastrointestinal cancers
Joana Lopes, Daniela Lopes, Mahzad Motallebi, et al.
Bioengineering & Translational Medicine (2025)
Open Access | Times Cited: 1
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment
Anita K. Bakrania, Gang Zheng, Mamatha Bhat
Pharmaceutics (2021) Vol. 14, Iss. 1, pp. 41-41
Open Access | Times Cited: 46
Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy
Elena Radu, Augustin Semenescu, Ștefan Ioan Voicu
Polymers (2022) Vol. 14, Iss. 23, pp. 5249-5249
Open Access | Times Cited: 35
Nanoparticle drug delivery systems in hepatocellular carcinoma: A focus on targeting strategies and therapeutic applications
Sayali Pravin Metkar, Gasper Fernandes, Prerana D. Navti, et al.
OpenNano (2023) Vol. 12, pp. 100159-100159
Open Access | Times Cited: 19
Construction of pH-responsive polydopamine coated magnetic layered hydroxide nanostructure for intracellular drug delivery
Zhaoyun Liu, Xi Wang, Xiaoxu Chen, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 182, pp. 12-20
Closed Access | Times Cited: 24
TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems
Muhammad Asim Farooq, Natalie L. Trevaskis
Pharmaceutical Research (2022) Vol. 40, Iss. 1, pp. 245-263
Open Access | Times Cited: 23
A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review)
Liming Zheng, Xingyue Chen, Li Zhang, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 14
Hyaluronic acid-zein shell-core biopolymer nanoparticles enhance hepatocellular carcinoma therapy of celastrol via CD44-mediated cellular uptake
Congjian He, Jiahui Zhou, Xixi Wu, et al.
International Journal of Biological Macromolecules (2024), pp. 136096-136096
Closed Access | Times Cited: 6
Endogenous NO-release multi-responsive hollow mesoporous silica nanoparticles for drug encapsulation and delivery
Shu Wu, Jinjing Shi, Xia Chen, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 227, pp. 113346-113346
Closed Access | Times Cited: 13
The role of myeloid-derived suppressor cells in liver cancer
Shiyue Zhou, Zixuan Zhao, Hao Zhong, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Seeing beyond words: nanotechnology in hepatocellular carcinoma - a bibliometric study
Talaiti Tuergan, Aimitaji Abulaiti, Alimu Tulahong, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Drug delivery for platinum therapeutics
Hui Liu, Jiahui Zou, Xiaotong Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 503-523
Closed Access
Current status and recent progress of nanomaterials in transcatheter arterial chemoembolization therapy for hepatocellular carcinoma
Jia Sun, Hailiang Li, Wenjun Zhou, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access
Bibliometric analysis of nanoparticle research for diagnostics and therapeutics in hepatocellular carcinoma
Xiaoqing Li, Yue Li, Jingyan Zhu, et al.
Discover Nano (2025) Vol. 20, Iss. 1
Open Access
Metal Nanoparticles in Liver Cancer Therapy: Advances, Challenges, and Future Directions
C. Uma, K. Gobikanila, P. R. Jeyaramraja, et al.
Next research. (2025), pp. 100421-100421
Closed Access
Construction of multifunctional mesoporous silicon nano-drug delivery system and study of dual sensitization of chemo-photodynamic therapy in vitro and in vivo
Jiaxi Xu, Jingwen Zhang, Jinping Song, et al.
Journal of Colloid and Interface Science (2022) Vol. 628, pp. 271-285
Closed Access | Times Cited: 15
Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma
Rebeca Escutia-Gutiérrez, Ana Sandoval-Rodríguez, Adalberto Zamudio‐Ojeda, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 21, pp. 6867-6867
Open Access | Times Cited: 9
ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells
Peng Wu, X M Wang, Min Yin, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4465-4493
Open Access | Times Cited: 3
Facile and Green Fabrication of Highly Competent Surface-Modified Chlorogenic Acid Silver Nanoparticles: Characterization and Antioxidant and Cancer Chemopreventive Potential
Tamanna Roy, Surya Kanta Dey, Ananya Pradhan, et al.
ACS Omega (2022) Vol. 7, Iss. 51, pp. 48018-48033
Open Access | Times Cited: 14
Identification of Ferroptosis‐related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy
Shichao Long, Yuqiao Chen, Ya Wang, et al.
Cancer Medicine (2022) Vol. 12, Iss. 2, pp. 2134-2147
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top